A new report estimates that the overall health costs of climate change already exceed $820 billion each year. The healthcare sector alone is responsible for nearly 5 percent of worldwide greenhouse gas emissions. According to a December 2020 Health Affairs study, “health damages stemming from U.S. [healthcare] pollution in 2013 [are] on the same order of magnitude as deaths from preventable medical errors.” Unfortunately, many of the most vulnerable communities are impacted by the harmful effects of climate change.
Discussions surrounding diversity, equity and inclusion (DE&I) are critically important to the healthcare distribution industry as this work ultimately strengthens the industry’s ability to deliver safe, affordable and efficient healthcare to patients across the nation. Earlier this month, HDA hosted a virtual discussion with four industry leaders who are fostering belonging within their organizations.
Protecting the steady supply of critical, lifesaving medicines to hospitals, pharmacies, providers and patients is a complex process in normal times. During COVID-19, patient demand for personal protective equipment (PPE) and other products has escalated significantly, adding new and unique challenges for HDA distributor members who are working around the clock to meet the daily healthcare needs of all Americans.
For the past year, I have watched the men and women of the healthcare distribution industry go above and beyond on a daily basis to make sure medicines, vaccines, PPE and other medical supplies reached patients and providers across the country. Their energy, determination and commitment have ensured a resilient supply chain during the most challenging days of the COVID-19 pandemic and a distribution network that has continued to deliver value each and every day.
On March 11, The 19th, an independent, nonprofit newsroom reporting on gender, politics and policy, hosted a virtual summit about healthcare equity in the context of the nation’s ongoing fight to defeat COVID-19. The event featured important and unique perspectives from the women directing the Biden-Harris administration’s pandemic response as well as other public health, health policy and healthcare industry leaders.